Abstract
Hair loss is a common complaint, and an understanding of the hair cycle is vital in order to interpret whether hair loss is secondary to medication use, as the use of prescription medications is widespread. When there is a temporal association between the onset of hair loss and the commencement of a medication, the medication is commonly presumed to have caused the hair loss. Drug-induced alopecia is a result of either rapid termination of the normal growth phase (anagen effluvium) or a premature conversion of actively growing hairs into the dormant, resting phase (telogen effluvium). Hair loss, in particular telogen effluvium, may, however, occur in response to a number of triggers including fever, hemorrhage, severe illness, and stress. Because hair loss is often delayed and because diffuse alopecia often begins sub-clinically, it may be challenging to determine the primary of alopecia. As a rule of thumb, adverse drug reactions are reversible provided the causative drug is avoided; however, identifying the culprit medication can be difficult. This chapter will review the normal hair cycle and discuss the major drugs that have been associated with alopecia, along with their mechanism (s) of action.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Suggested Reading
Abbasi NR, Orlow SJ. Lichen planopilaris noted during etanercept therapy in a child with severe psoriasis. Pediatr Dermatol. 2009;26(1):118.
Apsner R, Horl WH, Sunder-Plassmann G. Dalteparin-induced alopecia in hemodialysis patients: reversal by regional citrate anticoagulation. Blood. 2001;97(9):2914–5.
Balter S, Hopewell JW, Miller DL, Wagner LK, Zelefsky MJ. Fluoroscopically guided interventional procedures: a review of radiation effects on patients’ skin and hair. Radiology. 2010;254(2):326–41.
Bergfeld WF. Retinoids and hair growth. J Am Acad Dermatol. 1998;39(2):S86–9.
Chon SY, Champion RW, Geddes ER, Rashid RM. Chemotherapy-induced alopecia. J Am Acad Dermatol. 2012;67(1):37–47.
Clarke JT, Price H, Clarke S, George R, Miller JJ. Acquired kinking of the hair caused by acitretin. J Drugs Dermatol. 2007;6(9):937–8.
Cöster C, Tyrenius A. Reversible hair loss with nitrofurantoin treatment. Läkartidningen. 1971;68(30):3366 (Swedish).
Duvic M, Lemak NA, Valero V, Hymes SR, Farmer KL, Hortobagyi GN, et al. A randomized trial of minoxidil in chemotherapy-induced alopecia. J Am Acad Dermatol. 1996;35(1):74–8.
Eker HE, Cok OY, Aribogan A. Alopecia associated with gabapentin in the treatment of neuropathic pain. J Pain Symptom Manage. 2009;37(3):e5–6.
Flesch P. Inhibition of keratinizing structures by systemic drugs. Pharmacol Rev. 1963;58:653.
Garcovich S, Manco S, Zampetti A, et al. Onset of lichen planopilaris during treatment with etanercept. Br J Dermatol. 2008;158:1161–3.
Goh C. Hepatitis C treatment and alopecia totalis. J Investig Dermatol Symp Proc. 2013;16:S59–60.
Graeber CW, Lapkin RA. Metoprolol and alopecia. Cutis. 1981;28(6):633–4.
Grevelman EG, Breed WPM. Prevention of chemotherapy-induced hair loss by scalp cooling. Ann Oncol. 2005;16(3):352–8.
Harrison S, Sinclair R. Telogen effluvium. Clin Exp Dermatol. 2002;27:389–95.
Hedenmalm K, Sundström A, Spigset O. Alopecia associated with treatment with selective serotonin reuptake inhibitors (SSRIs). Pharmacoepidemiol Drug Saf. 2006;15(10):719–25.
Hilder RJ. Propranolol and alopecia. Cutis. 1979;24(1):63–4.
Holler PD, Cotsarelis G. Retinoids putting the “a” in alopecia. J Invest Dermatol. 2013;133:285–6.
Kartal ED, Alpat SN, Ozgunes I, Usluer G. Reversible alopecia universalis secondary to PEG-interferon alpha-2b and ribavirin combination therapy in a patient with chronic hepatitis C virus infection. Eur J Gastroenterol Hepatol. 2007;19(9):817–20.
Leaker B, Whitworth JA. Alopecia associated with captopril treatment. Aust N Z J Med. 1984;14(6):866.
Martin CM, Southwick EG, Maibach HI. Propranolol induced alopecia. Am Heart J. 1973;86(2):236–7.
Mcgovern B, Garan H, Kelly E, Ruskin JN. Adverse reactions during treatment with amiodarone hydrochloride. Br Med J. 1983;287(6386):175–80.
McKinney PA, Finkenbine RD, DeVane CL. Alopecia and mood stabilizer therapy. Ann Clin Psychiatry. 1996;8(3):183–5.
Mercke Y, Sheng H, Khan T, Lippmann S. Hair loss in psychopharmacology. Ann Clin Psychiatry. 2000;12(1):35–42.
Miwa H, Kondo T. Hair loss induced by dopamine agonist: case report and review of the literature. Parkinsonism Relat Disord. 2003;10(1):51–2.
Mortimer PS, Dawber RPR. Hair loss and lithium. Int J Dermatol. 1984;23(9):603–4.
Motel PJ. Captopril and alopecia: a case report and review of known cutaneous reactions in captopril use. J Am Acad Dermatol. 1990;23(1):124–5.
Munstedt K, Manthey N, Sachsse S, Vahrson H. Changes in self-concept and body image during alopecia induced cancer chemotherapy. Support Care Cancer. 1997;5:139–43.
Nagao T, Ibayashi S, Fujii K, Sugimori H, Sadoshima S, Fujishima M. Treatment of warfarin-induced hair loss with ubidecarenone. Lancet. 1995;346(8982):1104–5.
Omazzi B, Prada A, Borroni G, Sacrini F. Irreversible slopecia universalis during treatment with pegylated interferon-ribavirin for chronic hepatitis C virus infection: case report and published work review. Hepatol Res. 2012;42:1248–51.
Orfanos C, Happle R. Hair and hair diseases. Berlin: Springer; 1990.
Patel M, Harrison S, Sinclair R. Drugs and hair loss. Dermatol Clin. 2013;31:67–73.
Pearce DJ, Klinger S, Ziel KK, Murad EJ, Rowell R, Feldman SR. Low-dose acitretin is associated with fewer adverse events than high-dose acitretin in the treatment of psoriasis. Arch Dermatol. 2006;142:1000–4.
Pettignano R, Heard ML, Labuz MD, Wagoner SF, Fortenberry J. Hair loss after extracorporeal membrane oxygenation. Pediatr Crit Care Med. 2003;4(3):363–6.
Piraccini BM, Iorizzo M, Rech G, Tosti A. Drug-induced hair disorders. Curr Drug Saf. 2006;1:301–5.
Podlipnik S, Giavedoni P, San-Román L, Ferrando J. Square alopecia: a new type of transient alopecia of the scalp following fluoroscopically endovascular embolization. Int J Trichology. 2013;5(4):201–3.
Rosman IS, Anadkat MJ. Tufted hair folliculitis in a woman treated with trastuzumab. Target Oncol. 2010;5:295–6.
Ruiz-Ramos J, Salavert-Lleti M, Monte-Boquet E, Lorente-Fernández L, Gil-Gómez I, Poveda-Andrés JL. Anidulafungin-induced alopecia. Ann Pharmacother. 2014;48(5):660–2.
Samuel LM, Davie M, Starkey IR. Amiodarone and hair loss. Postgrad Med J. 1992;68(803):771.
Sarris E, Tsele E, Bagiatoudi G, Salpigidis K, Stavrianaki D, Kaklamanis L, et al. Diffuse alopecia in a hemodialysis patient caused by a low-molecular-weight heparin, tinzaparin. Am J Kidney Dis. 2003;41(5):15.
Shapiro J, Wiseman M, Lui H. Practical management of hair loss. Can Fam Physician. 2000;46:1469–77.
Shelley ED, Shelley WB. Alopecia and drug eruption of the scalp associated with a new beta-blocker, nadolol. Cutis. 1985;35(2):148–9.
Signore RJ, von Weiss J. Alopecia of myxedema: clinical response to levothyroxine sodium. J Am Acad Dermatol. 1991;25(5):902–4.
Tosti A, Pazzaglia M. Drug reactions affecting hair: diagnosis. Dermatol Clin. 2007;25(2):223–31.
Tosti A, Misciali C, Bardazzi F, Fanti PA, Varotti C. Telogen Effluvium due to recombinant interferon alpha-2b. Dermatology. 1992;184(2):124–5.
Tosti A, Piraccini BM, Vincenzi C, Misciali C. Permanent alopecia after busulfan chemotherapy. Br J Dermatol. 2005;152:1056–8.
Tricot L, Lebbé C, Pillebout E, Martinez F, Legendre C, Thervet E. Tacrolimus-induced alopecia in female kidney-pancreas transplant recipients. Transplantation. 2005;80(11):1546–9.
Umlas J, Harken DE. Warfarin-induced alopecia. Cutis. 1988;42(1):63–4.
Wang YY, Po HL. Enoxaparin-induced alopecia in patients with cerebral venous thrombosis. J Clin Pharm Ther. 2006;31(5):513–7.
Warnock JK, Sieg K, Willsie D, Stevenson EK, Kestenbaum T. Drug-related alopecia in patients treated with tricyclic antidepressants. J Nerv Ment Dis. 1991;179(7):441–2.
Yoshioka H, Matsuda I. Loss of hair related to gentamicin treatment. JAMA. 1970;211(1):123.
Yun SJ, Kim SJ. Hair loss pattern due to chemotherapy-induced anagen effluvium: a cross-sectional observation. Dermatology. 2007;215:36–40.
Zuk DM, Koh A, Imes S, Shapiro AM, Senior PA. Three cases of alopecia following clinical islet transplantation. Am J Transplant. 2011;11:163–8.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2015 Springer-Verlag London
About this chapter
Cite this chapter
Lesiak, K., Bartlett, J.R., Frieling, G.W. (2015). Drug-Induced Alopecia. In: Hall, J., Hall, B. (eds) Cutaneous Drug Eruptions. Springer, London. https://doi.org/10.1007/978-1-4471-6729-7_20
Download citation
DOI: https://doi.org/10.1007/978-1-4471-6729-7_20
Publisher Name: Springer, London
Print ISBN: 978-1-4471-6728-0
Online ISBN: 978-1-4471-6729-7
eBook Packages: MedicineMedicine (R0)